title: Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: report of an autopsy case.
abstract: An autopsy case of amyotrophic lateral sclerosis with dementia (ALS-D) showing clinically overt parkinsonism and severe degeneration of the substantia nigra is reported. The patient was a 78-year-old man who died after a 2-year clinical course characterized by parkinsonism that was responsive to Levodopa (L-DOPA) treatment. Motor neuron symptoms and dementia were not apparent ante-mortem. The autopsy demonstrated the severe degeneration of the substantia nigra without alpha-synucleinopathy-related changes. Finely granular mineralization of necrotic neurons was a unique finding in the substantia nigra. The mild loss of spinal anterior horn cells, the appearance of several Bunina bodies and the degeneration of the hippocampal subiculum and temporal cortex were also noted. A small number of ubiquitinated intra-cytoplasmic inclusions were found in neurons of the dentate fascia of the hippocampus and the temporal and frontal cortices. Although the degeneration of the substantia nigra is a common finding in ALS-D, patients seldom develop clinically overt parkinsonism. This case indicates that patients with ALS-D rarely present with predominantly parkinsonian clinical features and these symptoms and signs can be improved by L-DOPA treatment.
authors.affiliation: Department of Pathology, Osaka Red Cross Hospital, Tennoji, Osaka 543-8555, Japan. masa-s@sings.jp
authors.forename: Masayuki
authors.initials: M
authors.lastname: Shintaku
authors.forename: Kiyomitsu
authors.initials: K
authors.lastname: Oyanagi
authors.forename: Daita
authors.initials: D
authors.lastname: Kaneda
mesh_terms: D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D001344:Autopsy; D003704:Dementia / Q000209:etiology / Q000473:pathology*; D003937:Diagnosis, Differential; D015259:Dopamine Agents / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D010300:Parkinson Disease / Q000473:pathology; D020734:Parkinsonian Disorders / Q000209:etiology*; D013378:Substantia Nigra / Q000473:pathology*
chemical_list: D015259:Dopamine Agents; D007980:Levodopa